Avanos Medical (NYSE:AVNS) issued an update on its FY 2018 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.75-1.90 for the period.
AVNS traded down $7.57 during trading on Tuesday, reaching $51.22. The stock had a trading volume of 6,095 shares, compared to its average volume of 265,051. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 21.88 and a beta of 1.86. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.48 and a quick ratio of 2.18. Avanos Medical has a 1-year low of $43.78 and a 1-year high of $72.96.
Avanos Medical (NYSE:AVNS) last released its earnings results on Tuesday, November 6th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The firm had revenue of $165.10 million during the quarter, compared to the consensus estimate of $166.57 million. Avanos Medical had a return on equity of 7.61% and a net margin of 11.85%. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year. Equities analysts expect that Avanos Medical will post 1.87 EPS for the current fiscal year.
AVNS has been the subject of a number of recent research reports. Zacks Investment Research downgraded Avanos Medical from a buy rating to a hold rating in a research report on Friday, October 12th. Barclays initiated coverage on Avanos Medical in a research report on Monday, October 15th. They set an equal weight rating and a $69.00 price objective for the company. Morgan Stanley increased their price objective on Avanos Medical from $58.00 to $60.00 and gave the company an underweight rating in a research report on Wednesday, August 8th. KeyCorp increased their price objective on Avanos Medical from $66.00 to $75.00 and gave the company an overweight rating in a research report on Wednesday, August 8th. Finally, Raymond James upgraded Avanos Medical from a market perform rating to an outperform rating in a research report on Tuesday, August 21st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The company has an average rating of Hold and an average target price of $69.25.
TRADEMARK VIOLATION NOTICE: This story was posted by Macon Daily and is the sole property of of Macon Daily. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://macondaily.com/2018/11/06/avanos-medical-avns-issues-fy-2018-earnings-guidance.html.
About Avanos Medical
Avanos Medical, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.
Read More: Bear Market – How and Why They Occur
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.